Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings (2016)
- Authors:
- USP affiliated authors: CHAMMAS, ROGER - FM ; BUCHPIGUEL, CARLOS ALBERTO - FM
- Unidade: FM
- DOI: 10.1016/j.canlet.2015.11.030
- Subjects: METÁSTASE NEOPLÁSICA; MELANOMA ANIMAL; ANTICORPOS MONOCLONAIS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Cancer Letters
- ISSN: 0304-3835
- Volume/Número/Paginação/Ano: v. 371, n. 2, p. 151–160, 2016
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: implied-oa
-
ABNT
AGUIAR, Rodrigo Barbosa de; PARISE, Carolina Bellini; SOUZA, Carolina Rosal Teixeira; et al. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings. Cancer Letters, Amsterdam, v. 371, n. 2, p. 151–160, 2016. Disponível em: < http://dx.doi.org/10.1016/j.canlet.2015.11.030 > DOI: 10.1016/j.canlet.2015.11.030. -
APA
Aguiar, R. B. de, Parise, C. B., Souza, C. R. T., Braggion, C., Quintilio, W., Moro, A. M., et al. (2016). Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings. Cancer Letters, 371( 2), 151–160. doi:10.1016/j.canlet.2015.11.030 -
NLM
Aguiar RB de, Parise CB, Souza CRT, Braggion C, Quintilio W, Moro AM, Marques FLN, Buchpiguel CA, Chammas R, Moraes JZ de. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings [Internet]. Cancer Letters. 2016 ; 371( 2): 151–160.Available from: http://dx.doi.org/10.1016/j.canlet.2015.11.030 -
Vancouver
Aguiar RB de, Parise CB, Souza CRT, Braggion C, Quintilio W, Moro AM, Marques FLN, Buchpiguel CA, Chammas R, Moraes JZ de. Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings [Internet]. Cancer Letters. 2016 ; 371( 2): 151–160.Available from: http://dx.doi.org/10.1016/j.canlet.2015.11.030 - Assessment of the animal biodistribution of seven glucose appended [99mTc] technetium complexes in a murine melanoma tumor model
- Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200
- Comparisson of 99mTc-DMSA-V, 99mTc-MIBI and [18F]FDG for melanoma detection
- Comparison of 99mTc DMSA-V, 99mTc-MIBI and [18F] FDG for melanoma detection in cell expressing P-glicoprotein
- Binding affinity, specificity and comparative biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and its humanized version Rebmab200
- Neonatal seizures: The overlap between diagnosis of metabolic disorders and structural abnormalites
- Vascular endothelial growth factor as a biomarker for endostatin gene therapy
- Combined effects of dacabarzine and R715, an antagonist of the bradykinin receptor subtype I, impaired melanoma associated angiogenesis
- Interaction between braf inhibitor PLX-4720 and CDKS inhibitors can sensitize melanoma cells with braf V600E mutation
- Classificação e nomenclatura anátomo patológica de tumores
Informações sobre o DOI: 10.1016/j.canlet.2015.11.030 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
